Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCGI) next month. "We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world's first clinically proven nasal COVID-19 vaccine," he said.
Show more Show less!1 New UpdateClick here for latest updates
N. Korea's new suspected Covid-19 cases fall below 20,000
North Korea's new suspected Covid-19 cases dropped below 20,000, according to its state media Sunday. More than 19,310 people showed symptoms of fever over a 24-hour period until 6 p.m. the previous day, the official Korean Central News Agency said, citing data from the state emergency epidemic prevention headquarters, Yonhap news ageny reported.
Assam floods
Incessant rains in the past few days trigger mayhem in various parts; the flood situation in Kampur deteriorates further
Fire breaks out in Mumbai's Borivali
Fire broke out on the 14th floor of a building 'Dheeraj Savera' in Mumbai's Borivali. Six fire tenders rushed to the spot. 14 people trapped in two apartments were rescued by the fire brigade. No casualties were reported. Fire has been brought under control.
Apple store workers vote to form their first US union
A majority of employees at a US Apple store have voted to form a union, a first for the tech giant, which has so far tried to discourage unionizing attempts. Of the 110 employees at the Towson, Maryland shop, 65 voted in favor and 33 against, according to a live count broadcast Saturday by the federal agency overseeing the vote.
US court approves LATAM Airlines plan to exit bankruptcy
A New York City court approved a plan by Latin America's largest airline, LATAM Airlines, to exit bankruptcy under US law, the carrier announced.
Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech has said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCGI) next month.